ALC logo

ALC
Alcon Inc. - Registered Shares

566
Mkt Cap
$33.04B
Volume
2M
52W High
$92.55
52W Low
$61.84
PE Ratio
40.64
ALC Fundamentals
Price
$67.78
Prev Close
$67.93
Open
$67.89
50D MA
$73.25
Beta
0.74
Avg. Volume
1.41M
EPS (Annual)
$1.99
P/B
1.49
Rev/Employee
$400,932.85
$43,337.51
Loading...
Loading...
News
all
press releases
Reasons to Retain STE Stock in Your Portfolio for Now
STERIS' Healthcare and AST segments post solid gains and milestones, but FX volatility, tariffs and global macro pressures threaten earnings variability.
News Placeholder
More News
News Placeholder
EYE Q1 Earnings & Revenues Beat Estimates, Operating Margin Expands
National Vision beats EPS and revenue estimates as comps rise 4.5% and operating margin jumps 320 bps; 2026 guidance reiterated.
News Placeholder
PBH Q4 Earnings & Revenues Miss Estimates, Margins Down
Prestige Consumer misses Q4 EPS and revenue estimates as Clear Eyes supply limits and Middle East shipping disruptions pressure sales and margins.
News Placeholder
STE Q4 Earnings & Revenues Miss, Stock Dips in Aftermarket Trading
STERIS posts Q4 adjusted EPS of $2.83 and revenues of $1.59 billion, both slight misses; shares dip after hours despite broad growth and FY27 guidance.
News Placeholder
HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut
Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets its FY27 growth outlook.
News Placeholder
GMED Stock Rises on Q1 Earnings & Revenue Beat, '26 EPS View Raised
Globus Medical beats Q1 EPS estimates by 22% as revenues rise 27% to $759.9M; margins widen and 2026 EPS outlook up, lifting shares 5.8%.
News Placeholder
Here's Why Alcon (ALC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
News Placeholder
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the three months ending March 31, 2026. For the first quarter of 2026, sales were $2.7 billion, up 10% on a...
News Placeholder
ALC vs. PEN: Which Stock Should Value Investors Buy Now?
ALC vs. PEN: Which Stock Is the Better Value Option?
News Placeholder
Alcon Announces Results of 2026 Annual General Meeting
Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2026 Annual General Meeting (AGM). A total of 283,222,421 shares with a nominal value of CHF 0.04 each, representing an aggregate...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available